Atul Pande, Director at Immunovant, Inc. (IMVT), bought 15,000 shares at $5.60 ($84K) on 2022-09-30, disclosed to the SEC on 2022-10-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| IMVT | SELL | 2026-06-26 | $57K | — | Filing → |
| IMVT | SELL | 2026-06-16 | $51K | — | Filing → |
| IMVT | SELL | 2026-05-20 | $192K | — | Filing → |